X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (293) 293
Publication (47) 47
Book / eBook (16) 16
Book Chapter (5) 5
Book Review (4) 4
Newspaper Article (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (184) 184
male (103) 103
adult (89) 89
immunology (68) 68
female (67) 67
index medicus (66) 66
infectious diseases (65) 65
hiv (64) 64
middle aged (62) 62
aids (60) 60
hiv infections - drug therapy (44) 44
article (37) 37
hiv infection (36) 36
hiv infections - immunology (36) 36
virology (36) 36
acquired immunodeficiency syndrome - complications (33) 33
drug therapy (29) 29
health aspects (29) 29
oncology (29) 29
cd4 lymphocyte count (28) 28
research (27) 27
antiretroviral therapy, highly active (26) 26
hiv infections - virology (26) 26
human immunodeficiency virus--hiv (26) 26
human-immunodeficiency-virus (26) 26
highly active antiretroviral therapy (23) 23
hiv infections - complications (23) 23
viral load (23) 23
cancer (22) 22
active antiretroviral therapy (20) 20
human immunodeficiency virus (20) 20
anti-hiv agents - therapeutic use (19) 19
antiretroviral therapy (19) 19
infection (19) 19
infections (19) 19
animals (18) 18
antiviral agents (18) 18
care and treatment (18) 18
clinical trials (18) 18
hematology (18) 18
risk factors (18) 18
adolescent (17) 17
aged (17) 17
lymphocytes (17) 17
sarcoma, kaposi - etiology (16) 16
t-cells (16) 16
hiv infections - therapy (15) 15
hiv-1 (15) 15
acquired immune deficiency syndrome (14) 14
acquired immune deficiency syndrome--aids (14) 14
chemotherapy (14) 14
kaposi's sarcoma (14) 14
microbiology (14) 14
replication (14) 14
virus diseases (14) 14
cd4-positive t-lymphocytes - immunology (13) 13
cohort studies (13) 13
medicine, general & internal (13) 13
recombinant proteins - therapeutic use (13) 13
research article (13) 13
viruses (13) 13
abridged index medicus (12) 12
disease progression (12) 12
drug therapy, combination (12) 12
hiv infections (12) 12
hiv patients (12) 12
hiv-infection (12) 12
immunodeficiency-virus type-1 (12) 12
interleukin-2 (12) 12
medicine, research & experimental (12) 12
rna, viral - blood (12) 12
sarcoma, kaposi - therapy (12) 12
therapy (12) 12
treatment outcome (12) 12
acquired immunodeficiency syndrome - immunology (11) 11
hiv/aids (11) 11
immune-deficiency syndrome (11) 11
physiological aspects (11) 11
rna (11) 11
sarcoma, kaposi - drug therapy (11) 11
t lymphocytes (11) 11
zidovudine (11) 11
analysis (10) 10
antiretroviral drugs (10) 10
cells (10) 10
development and progression (10) 10
follow-up studies (10) 10
hiv infections - blood (10) 10
hiv-1 - isolation & purification (10) 10
immunotherapy (10) 10
infected patients (10) 10
medical research (10) 10
prospective studies (10) 10
virus replication (10) 10
acquired immunodeficiency syndrome (9) 9
aids/hiv (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
cd4 antigen (9) 9
cell biology (9) 9
cells, cultured (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1588 - 1588
Introduction: EPOCH-based chemotherapy is considered a preferred first-line treatment for HIV-associated diffuse large B-cell lymphoma (DLBCL) and primary... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2872 - 2872
Introduction: Six cycles of rituximab plus infusional EPOCH is considered a preferred regimen for first-line treatment of HIV-associated diffuse large B-cell... 
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2019, p. clincanres.1044.2019
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2019, Volume 14, Issue 1, p. e0210965
Journal Article
Blood advances, ISSN 2473-9529, 12/2018, Volume 2, Issue 24, pp. 3618 - 3626
HIV-associated lymphomas (HALs) have high rates of latent infection by gammaherpesviruses (GHVs). We hypothesized that proteasome inhibition would induce lytic... 
Journal Article
Journal Article
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 03/2018, Volume 18, Issue 3, pp. 180 - 190.e2
Journal Article
Clinical lymphoma, myeloma & leukemia, ISSN 2152-2650, 3/2018, Volume 18, Issue 3, pp. 180 - 190.e2
We performed a phase I trial of vorinostat (VOR) given on days 1 to 5 with R-EPOCH (rituximab plus etoposide, prednisone, vincristine, cyclophosphamide, and... 
Chemotherapy | Epstein-Barr virus | Lytic-inducing therapies | Histone deacetylase inhibitors | AIDS-related malignancies
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5_suppl, pp. TPS44 - TPS44
TPS44 Background: Immune checkpoint blockade (ICB) using agents that target the priming phase (i.e. CTLA-4) and effector phase (e.g. PD-1) of host immunity,... 
Journal Article
PLoS Pathogens, ISSN 1553-7366, 10/2017, Volume 13, Issue 10, pp. e1006613 - e1006613
Journal Article
18.